BRPI0407457A - Uso do dipiridamol com ácido acetilsalicìlico e um antagonista da angiotensina ii na prevenção de acidente vascular cerebral (avc) - Google Patents

Uso do dipiridamol com ácido acetilsalicìlico e um antagonista da angiotensina ii na prevenção de acidente vascular cerebral (avc)

Info

Publication number
BRPI0407457A
BRPI0407457A BR0407457-2A BRPI0407457A BRPI0407457A BR PI0407457 A BRPI0407457 A BR PI0407457A BR PI0407457 A BRPI0407457 A BR PI0407457A BR PI0407457 A BRPI0407457 A BR PI0407457A
Authority
BR
Brazil
Prior art keywords
dipyridamole
angiotensin
antagonist
stroke
acetylsalicylic acid
Prior art date
Application number
BR0407457-2A
Other languages
English (en)
Inventor
Lutz Hilbrich
James C Gilbert
David Michael Humphreys
Axel Riedel
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32870338&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0407457(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of BRPI0407457A publication Critical patent/BRPI0407457A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"USO DO DIPIRIDAMOL COM áCIDO ACETILSALICìLICO E UM ANTAGONISTA DA ANGIOTENSINA II NA PREVENçãO DE ACIDENTE VASCULAR CEREBRAL (AVC)". A presente invenção refere-se a um método de prevenção de acidente vascular cerebral (AVC) ou de redução do risco de acidente vascular cerebral em um paciente necessitado dela, especialmente em um paciente com risco de AVC ou de AVC secundário, usando dipiridamol em combinação com ácido acetilsalicílico (AAS) e um antagonista da angiotensina II, às composições farmacêuticas correspondentes e ao uso do dipiridamol para a fabricação de uma composição farmacêutica correspondente contendo uma combinação de dipiridamol, ácido acetilsalicílico e um antagonista da angiotensina II e um antagonista da angiotensina II.
BR0407457-2A 2003-02-13 2004-02-10 Uso do dipiridamol com ácido acetilsalicìlico e um antagonista da angiotensina ii na prevenção de acidente vascular cerebral (avc) BRPI0407457A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10306179A DE10306179A1 (de) 2003-02-13 2003-02-13 Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
EP03018212 2003-08-08
PCT/EP2004/001208 WO2004071385A2 (en) 2003-02-13 2004-02-10 Use of dipyridamole in combination with acetylsalicylic acid and an angiotensin ii antagonist for stroke prevention

Publications (1)

Publication Number Publication Date
BRPI0407457A true BRPI0407457A (pt) 2006-01-31

Family

ID=32870338

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0407457-2A BRPI0407457A (pt) 2003-02-13 2004-02-10 Uso do dipiridamol com ácido acetilsalicìlico e um antagonista da angiotensina ii na prevenção de acidente vascular cerebral (avc)

Country Status (29)

Country Link
US (5) US20040214802A1 (pt)
EP (2) EP1603573B8 (pt)
JP (1) JP2006517557A (pt)
KR (1) KR20050100676A (pt)
CN (1) CN1750830A (pt)
AR (1) AR043173A1 (pt)
AT (1) ATE395921T1 (pt)
AU (1) AU2004212305A1 (pt)
BR (1) BRPI0407457A (pt)
CA (1) CA2515941A1 (pt)
DE (2) DE10306179A1 (pt)
DK (1) DK1603573T3 (pt)
EA (1) EA200501231A1 (pt)
EC (1) ECSP055963A (pt)
ES (1) ES2308147T3 (pt)
HR (1) HRP20050713A2 (pt)
MX (1) MXPA05008572A (pt)
NO (1) NO20054216D0 (pt)
NZ (1) NZ542302A (pt)
PE (1) PE20050191A1 (pt)
PL (1) PL378204A1 (pt)
PT (1) PT1603573E (pt)
RS (1) RS20050618A (pt)
SI (1) SI1603573T1 (pt)
TW (1) TW200501957A (pt)
UA (1) UA83481C2 (pt)
UY (1) UY28182A1 (pt)
WO (1) WO2004071385A2 (pt)
ZA (1) ZA200505956B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10335027A1 (de) * 2003-07-31 2005-02-17 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Angiotensin II Rezeptor Antagonisten
DE10306179A1 (de) * 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe
CA2437709A1 (en) * 2003-08-08 2005-02-20 Boehringer Ingelheim Pharma Gmbh & Co. Kg Use of dipyridamole, acetylsalicylic acid and an angiotensin ii antagonist for treatment and prevention of vascular events
JP2005060359A (ja) * 2003-08-13 2005-03-10 Boehringer Ingelheim Pharma Gmbh & Co Kg 血管系病態の治療及び予防のためのジピリダモール、アセチルサリチル酸及びアンギオテンシンｉｉ拮抗薬の使用
WO2009080301A1 (en) * 2007-12-21 2009-07-02 Boehringer Ingelheim International Gmbh Treatment and prevention of ischaemic cerebral lesions and cerebrovascular cognitive impairment using a treatment regimen consisting of dipyridamole and an angiotensin ii receptor blocker in patients with previous stroke
US20100069326A1 (en) * 2008-02-14 2010-03-18 Wasimul Haque Combination Therapies to Treat Cardio- and Cerebro-Vascular Disorders
WO2009100534A1 (en) * 2008-02-14 2009-08-20 Kardiatech, Inc. Combination therapy to treat vascular disorders
WO2010097501A2 (en) * 2009-02-26 2010-09-02 Orion Corporation A combination treatment
US8633158B1 (en) * 2012-10-02 2014-01-21 Tarix Pharmaceuticals Ltd. Angiotensin in treating brain conditions
JP6925272B2 (ja) * 2015-01-28 2021-08-25 リアルイン ライフ サイエンス リミテッド ＰＰＡＲγ発現および核転座を促進する化合物およびそれの治療的使用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031458A (en) * 1958-02-05 1962-04-24 Ciba Pharm Prod Inc Isoindolines
US3031450A (en) 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
US3317279A (en) * 1963-03-15 1967-05-02 Pennsalt Chemicals Corp Polymorph of calcium disilicide and its method of preparation
JPS5671074A (en) * 1979-11-12 1981-06-13 Takeda Chem Ind Ltd 1,2-disubstituted-4-halogenoimidazole-5-acetic acid derivative
DE3000979A1 (de) 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
US4318477A (en) * 1980-09-22 1982-03-09 Kerpe Stase Z Pharmaceutical package
DE3124090A1 (de) 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
CA1334092C (en) 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
DE3627423A1 (de) 1986-08-13 1988-02-18 Thomae Gmbh Dr K Arzneimittel enthaltend dipyridamol oder mopidamol und o-acetylsalicylsaeure bzw. deren physiologisch vertraegliche salze, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung der thrombusbildung
CA1338238C (en) 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
US5015651A (en) 1988-01-07 1991-05-14 E. I. Du Pont De Nemours And Company Treatment of hypertension with 1,2,4-angiotensin II antagonists
SI9210098B (sl) 1991-02-06 2000-06-30 Dr. Karl Thomae Benzimidazoli, zdravila, ki te spojine vsebujejo, in postopek za njihovo pripravo
EP1013273A1 (en) 1998-12-23 2000-06-28 Novartis AG Use of AT-1 receptor antagonist or AT-2 receptor modulator for treating diseases associated with an increase of AT-1 or AT-2 receptors
SE9903028D0 (sv) * 1999-08-27 1999-08-27 Astra Ab New use
EP1093814A1 (en) * 1999-10-22 2001-04-25 Boehringer Ingelheim Pharma KG Use of dipyridamole or mopidamol in the manufacture of a medicament for the treatment and prevention of fibrin-dependent microcirculation disorders
JP2002138054A (ja) * 2000-08-25 2002-05-14 Takeda Chem Ind Ltd フィブリノーゲン低下剤
JP2002293742A (ja) * 2001-01-29 2002-10-09 Takeda Chem Ind Ltd 鎮痛・抗炎症剤
JP2003212758A (ja) * 2001-03-16 2003-07-30 Takeda Chem Ind Ltd 徐放性製剤の製造法
DE10306179A1 (de) * 2003-02-13 2004-08-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von Dipyridamol in Kombination mit Acetylsalicylsäure und einem Angiotensin II-Antagonisten zur Schlaganfall-Prophylaxe

Also Published As

Publication number Publication date
SI1603573T1 (sl) 2008-10-31
HRP20050713A2 (en) 2006-09-30
US20080188497A1 (en) 2008-08-07
CN1750830A (zh) 2006-03-22
KR20050100676A (ko) 2005-10-19
UA83481C2 (uk) 2008-07-25
JP2006517557A (ja) 2006-07-27
US20060241089A1 (en) 2006-10-26
US20040214802A1 (en) 2004-10-28
CA2515941A1 (en) 2004-08-26
EA200501231A1 (ru) 2006-02-24
NO20054216L (no) 2005-09-12
PE20050191A1 (es) 2005-04-12
TW200501957A (en) 2005-01-16
WO2004071385A2 (en) 2004-08-26
US20080113949A1 (en) 2008-05-15
WO2004071385A3 (en) 2005-01-06
MXPA05008572A (es) 2005-11-04
DK1603573T3 (da) 2008-09-15
NO20054216D0 (no) 2005-09-12
EP1603573B8 (en) 2009-04-01
EP1603573B1 (en) 2008-05-21
DE10306179A1 (de) 2004-08-26
NZ542302A (en) 2008-12-24
EP1733729A1 (en) 2006-12-20
PT1603573E (pt) 2008-06-26
PL378204A1 (pl) 2006-03-20
AR043173A1 (es) 2005-07-20
UY28182A1 (es) 2004-09-30
US20070004687A1 (en) 2007-01-04
EP1603573A2 (en) 2005-12-14
ZA200505956B (en) 2006-03-29
ECSP055963A (es) 2006-01-16
ES2308147T3 (es) 2008-12-01
ATE395921T1 (de) 2008-06-15
DE602004013937D1 (de) 2008-07-03
RS20050618A (sr) 2007-09-21
AU2004212305A1 (en) 2004-08-26

Similar Documents

Publication Publication Date Title
BRPI0316532B8 (pt) composições farmacêuticas compreendendo uma droga básica ou ácida, um tensoativo, e um ácido ou base solúvel em água fisiologicamente tolerável
BR0315115A (pt) Compostos, composições farmacêuticas, método para tratar ou prevenir doenças ou distúrbios em que se requer um antagonista de receptores de orexina humana, processo para a fabricação de composições farmacêuticas, e, uso de um ou mais compostos em combinação com outros compostos farmacologicamente ativos
BR0100046A (pt) Copolìmeros reticulados solúveis em água ou intumescìveis em água
BRPI0408490A (pt) composições que compreendem ácidos graxos e aminoácidos
WO2008129396A3 (en) Progesterone antagonist and selective progesterone modulator in the treatment of uterine bleeding
BRPI0407457A (pt) Uso do dipiridamol com ácido acetilsalicìlico e um antagonista da angiotensina ii na prevenção de acidente vascular cerebral (avc)
BR0107695A (pt) Tratamento de dano cerebral, espinhal e a nervos
MX2007004294A (es) Composiciones farmaceuticas que comprenden levetiracetam y proceso para su preparacion.
BRPI0406883A (pt) Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
BR0203902A (pt) Composições de compostos bioquìmicos envolvidos no metabolismo bioenergético das células e método de uso da mesma
BR0308290A (pt) Tratamento e prevenção de distúrbios inflamatórios
CL2007001178A1 (es) Compuestos fusionados derivados de tetrahidro[1,2,4]triazol[4,3-a]pirimidina, moduladores de receptores de glutamato metabotropicos (mglur5); compuestos intermediarios; composicion y combinacion farmaceutica que los comprende; y su uso en la preparacion de medicamentos para tratar enfermedades gastroesofagicas, la ansiedad y dolores.
WO2003061566A3 (en) Anti-cancer combination and use thereof
BR0215148A (pt) Composições farmacêuticas de agonista parcial 5ht4
BRPI0412919A (pt) combinação de antagonista de mglur2 e inibidor de ache para o tratamento de distúrbios neurológicos crÈnicos e/ou agudos
BRPI0519656A2 (pt) terapia de combinaÇço compreendendo telmisartan e hidroclorotiazida
BR0214810A (pt) Combinação de um inibidor de il-1/18 com um inibidor de tnf para o tratamento de inflamação
BR0213878A (pt) Processo para a formação de sólidos de ibuprofeno
BR0215124A (pt) Compostos e seus usos, composições farmacêutica e cosmética e uso cosmético de uma composição cosmética
WO2008120765A1 (ja) 鎮痛用組成物
EP1405639A4 (en) USE OF NA? + CHANNEL INHIBITORS AND ASPIRIN IN THE MANUFACTURE OF MEDICINES FOR THE PRODUCTION OF SYNERGISTIC ANALGESIA IN MAMMALS
WO2006087629A3 (en) Rapidly disintegrating composition of olanzapine
BRPI0416906A (pt) proteinúria tubular como um indicador para risco cardiovascular elevado
BR0210063A (pt) Composição estável e uso da mesma
BR0303110A (pt) Uso de dipiridamol, ácido acetilsalicìlico e um antagonista de angiotensina ii para tratamento e prevenção de eventos vasculares

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.